Development of monocrotaline-induced pulmonary hypertension is attenuated by a serotonin receptor antagonist

Lung

Volumn 178, Issue 2, 2000, Pages 63-73

  Miyata, Masayuki ^a   Ito, M ^a   Sasajima, T ^a   Ohira, H ^a   Sato, Y ^a   Kasukawa, R ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Monocrotaline; Proliferating cell nuclear antigen; Pulmonary hypertension; Serotonin receptor antagonist

Indexed keywords

CYCLINE; MONOCROTALINE; SARPOGRELATE; SEROTONIN 2A ANTAGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LUNG PARENCHYMA; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SEROTONINERGIC SYSTEM;

EID: 0034113345     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004080000009     Document Type: Article

References (29)

1. Domenighetti G, Leuenberger P, Feihl F (1997) Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension. Monaldi Arch Chest Dis 52:429-433
2. Fulton RM, Hutchinson EC, Jones AM (1952) Ventricular weight in cardiac hypertrophy. Br Heart J 14:413-420
3. Ghodsi F, Will JA (1981) Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol 240:H149-155
4. 2-serotonergic receptor antagonist. Thrombosis Haemost 65(4):415-420
5. Hegstrand LR, Eichelman B (1981) Determination of rat brain tissue catecholamines using liquid chromatography with electrochemical detection. Chromatogr 222:107-111
6. Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249-254
7. Hiragun T, Morita E, Tanaka T, Kameyoshi Y, Yamamoto S (1998) A fibrogenic cytokine, platelet-derived growth factor (PDGF), enhances mast cell growth indirectly via a SCF- and fibroblast-dependent pathway. J Invest Dermatol 111(2):213-217
8. Kanai Y, Hori S, Tanaka T, Yasuoka M, Watanabe K, Aikawa N, Hosoda Y (1993) Role of 5-hydroxytryptamine in the progression of monocrotaline-induced pulmonary hypertension in rats. Cardiovasc Res 27:1619-1623
9. Kay JM, Gillung TD, Hearth D (1967) Mast cells in the lungs of rats fed on Crotalaria spectabilis seeds. Am J Pathol 40:1031-1044
10. Koike T, Hirai K, Morita Y, Nozawa Y (1993) Stem cell factor-induced signal transduction in rat mast cells. Activation of phospholipase D but not phosphoinositide-specific phospholipase C in c-kit receptor stimulation. J Immunol 1;151(1):359-366
11. Lee SL, Wang WW, Lanzillo JJ, Fanburg BL (1994) Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol 266:L46-L52
12. Lehtosalo JI, Uusitalo H, Laakso J, Palkama A, Harkonen M (1984) Biochemical and immunohistochemical determination of 5-hydroxytryptamine located in mast cells in the trigeminal ganglion of the rat and guinea pig. Histochemistry 80(3):219-223
13. Loppnow H, Bil R, Hirt S, Schonbeck U, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD (1998) Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91(1):134-141
14. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R (1997) Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappa B and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96(7):2361-2367
15. McCann UD, Seiden LS, Rubin LJ, Ricaurte GA (1997) Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. JAMA 278(8):666-672
16. McGoon MD, Vanhoutte PM (1984) Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J Clin Invest 74:828-833
17. Miyamoto T, Sasaguri Y, Sasaguri T, Azakami S, Yasukawa H, Kato S, Arima N, Sugama K, Morimatsu M (1997) Expression of stem cell factor in human aortic endothelial and smooth muscle cells. Atherosclerosis 21;129(2):207-213
18. Miyata M, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, Kasukawa R (1995) Pulmonary hypertension in rats. 1. Role of bromodeoxyuridine-positive mononuclear cells and alveolar macrophages. Int Arch Allergy Immunol 108:281-296
19. Miyata M, Sakuma F, Yoshimura A, Ishikawa R, Nishimaki T, Kasukawa R (1995) Pulmonary hypertension in rats. 2. Role of interleukin-6. Int Arch Allergy Immunol 108:287-291
20. Nishio H, Inoue A, Nakata Y (1996) Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes. Arch Int Pharmacodyn Ther 331(2):189-202
21. Picard M, Olichon D, Gombert (1985) Determination of serotonin plasma by liquid chromatography with electrochemical detection. J Chromatogr 341:445-451
22. Pitt BR, Weng W, Steve AR, Blakely RD, Reynolds I, Davies P (1994) Serotonin increases DNA synthesis in rat proximal and distal pulmonary artery smooth muscle cells in culture. Am J Physiol 266:L178-186
23. 1 on pulmonary hypertension induced by monocrotaline in rats. Lung 177:77-88
24. 2 receptor antagonist, DV-7028. Arch Int Pharmacodyn Ther 319:114-128
25. Takasaki Y, Deng JS, Tan EM (1981) A nuclear antigen associated with cell proliferation and blast transformation. Its distribution in synchronized cells. J Exp Med 154:1899-1909
26. Takeoka O, Angevine DM, Lalich JJ (1962) Stimulation of mast cells in rats fed various chemicals. Am J Pathol 40:545-554
27. Weir EK, Reeve HL, Johnson G, Michelakis ED, Nelson DP, Archer SL (1998) A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension. Chest 114(3 Suppl):200S-204S
28. White SM, Roth RA (1988) Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats. Toxicol Appl Pharmacol 96:465-475
29. Wilson DW, Segall HJ, Pan LC, Lame MW, Estep JE, Morin D (1992) Mechanisms and pathology of monocrotaline toxicity. Crit Rev Toxicol 22:307-325